RESCUE and REVERSE Long-term Follow-up

计划入组 62 人 · 首次发布于 2018 年 1 月 23 日

A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

计划入组 31 人 · 首次发布于 2025 年 6 月 10 日

Gene Polymorphisms of Corticosteroid-induced Ocular Hypertension

计划入组 370 人 · 首次发布于 2017 年 8 月 16 日

ocular regenerative gene therapy (intraocular, glaucoma)

RS1 ocular gene therpay

arylsulfatase A gene therapy

CELL AND GENE THERAPY CATAPULT

United Kingdom

Ocular Therapeutix

United States

Ocular Therapeutix, Inc.

United States

Cirrus Therapeutics Secures $14.7M Seed Financing and SERI Collaboration to Advance Ocular Gene Therapy for Geographic Atrophy

Atsena Therapeutics and Nippon Shinyaku Partner to Advance Gene Therapy for LCA1

Cirrus Therapeutics Secures $11M to Advance Gene Therapy Targeting Age-Related Cause of Dry AMD